Jean Tang, MD
Dermatology · Stanford, CANPI 1568536878
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,135 of the $1,313 with a category attached, or 86.4%. Abeona Therapeutics, Inc. accounts for 90.2% of it on its own, with 3 other manufacturers making up the rest. 2025 is the largest year on record at $1,216, more than ten times the $14 reported in 2023. That places this record below the midpoint for dermatology clinicians in CA, where the typical reported total is $1,655.
Across 8 payments — averaging $164.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abeona Therapeutics, Inc.$1K
- Novartis$50
- Sanofi Pasteur Inc.$48
- Chiesi USA, Inc.$31
Across 12 payments — averaging $6804.51 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amicus Therapeutics, Inc.$82K
What the payments were for
- Travel & lodging$1,13586%
- Food & beverage$17814%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abeona Therapeutics, Inc. | 3 | $1,185 |
| Novartis | 1 | $50 |
| Sanofi Pasteur Inc. | 3 | $48 |
| Chiesi USA, Inc. | 1 | $31 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ZEVASKYN$1,135
How this compares
$1,313 in reported general payments places this provider in the 45th percentile of 1,875 dermatology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Triamcinolone Acetonide | 17 | $219 |
| Ketoconazole | 18 | $153 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Stanford
- Matthew LewisStanford$442K
- Justin KoStanford$237K
- David FiorentinoStanford$166K
- Paul YamauchiSanta Monica$2.9M
- Jennifer SoungSanta Ana$2.8M
- Robert GreenbergLivermore$2.6M
- Neal BhatiaSan Diego$2.5M
- April ArmstrongLos Angeles$2.3M
- Jeffrey CrowleyBakersfield$2.1M
- Jashin WuCorona$2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.